Patient-Centered Communication of Life Expectancy Estimates in Genitourinary Malignancies
- Trial number:
-
NCT03522155
- Trial phase:
- N/A
- Study type:
- Supportive interventions, Observational
- Overall status:
- Recruiting
Study start date
September, 2021
Scientific title
A Patient-Centered Approach to Integration of Life Expectancy Into Treatment Decision Making for Patients With Genitourinary Malignancy
Summary
Investigators will conduct a randomized trial to determine if providing patient-specific life expectancy estimates during treatment counseling via a targeted, patient-centered communication approach improves shared decision making and reduces rates of overtreatment of genitourinary malignancies.
Newly diagnosed clinical T1-2 prostate adenocarcinoma with Gleason scores of 7 or lessNewly diagnosed clinical T1a kidney cancer or renal masses < 4cm Newly diagnosed clinical T2 nonmetastatic urothelial carcinoma of the bladder
Under 18 years of ageSubjects with difficulty communicating or dementia Non-English speakers
Study design
Primary purpose:
Health Services Research,
Allocation:
Randomized,
Intervention model:
Parallel Assignment,
Intervention model description:
This randomized controlled trial will involve two arms,
Masking:
None (Open Label),
Conditions
Prostate Cancer Stage I, Kidney Cancer Stage I, Bladder Cancer Stage II, Prostate Cancer Stage II
Other study ID numbers
Pro00052777